DIAGNOS Strengthens Marketing Efforts
DIAGNOS Inc. (‘DIAGNOS’ or the ‘Corporation’) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in the early detection of vital health issues through its innovative FLAIRE platform powered by Artificial Intelligence (AI), has made significant strides by engaging Outside The Box Capital Inc. (OTB) for marketing and promotional support.
Details of the Agreement
Under the terms set forth in the recently signed agreement, OTB is set to receive CA$50,000 as an upfront cash payment for services rendered from January 13, 2025, to April 13, 2025. This engagement showcases DIAGNOS’s commitment to enhancing its market presence and overall brand recognition within the health sector.
Promotional Strategies
OTB specializes in providing digital marketing services tailored for small to medium-sized public companies. As part of DIAGNOS's strategy, OTB will utilize various marketing and distribution channels to disseminate information about the Corporation effectively. Their approach will focus on utilizing social media platforms and other innovative strategies aimed at boosting company visibility.
Commitment to Transparency
It's noteworthy that OTB is acting independently from DIAGNOS. At present, OTB and its principals hold no direct or indirect interests in DIAGNOS's securities, ensuring that the promotion remains objective and transparent. Such measures are crucial to maintaining integrity in the marketing practices of publicly traded companies.
Regulatory Considerations
This engagement with OTB is contingent upon the oversight and acceptance by the TSX Venture Exchange, further reinforcing the need for compliance with relevant regulations in corporate governance.
About DIAGNOS
DIAGNOS is a prominent publicly traded Canadian entity focused on the early detection of critical health conditions through its advanced FLAIRE AI platform. This platform supports rapid adaptation and development of applications like CARA (Computer Assisted Retina Analysis). The sophisticated image enhancement algorithms employed by CARA yield clearer and more analyzable retinal images, providing a cost-effective solution for real-time screening of substantial patient volumes.
Exploring Further Innovations
The advancement of AI technologies continues to shape the healthcare landscape, and DIAGNOS is at the forefront of this transformation. By leveraging state-of-the-art technology, DIAGNOS aims to enhance diagnostic accuracy and improve patient outcomes. Their commitment to innovation is evident not only in their FLAIRE platform but also in ongoing discussions around the integration of AI in various healthcare applications.
Frequently Asked Questions
What services is OTB providing to DIAGNOS?
OTB is providing marketing and promotional services to enhance DIAGNOS's visibility through various channels, including social media.
How much is DIAGNOS compensating OTB?
DIAGNOS has agreed to compensate OTB CA$50,000 for their services during the engagement period.
What is the FLAIRE platform?
The FLAIRE platform developed by DIAGNOS uses AI to assist in the early detection of critical health issues.
Why is the agreement with OTB important for DIAGNOS?
This agreement is crucial as it aims to significantly increase DIAGNOS's market presence and awareness among potential clients and stakeholders.
Is OTB independent from DIAGNOS?
Yes, OTB is acting at arm's length from DIAGNOS and currently does not hold any interest in DIAGNOS's securities.
